CURIS INC
Qualité des données : 100%
CRIS
NASDAQ
Manufacturing
Chemicals
0,50 €
▼
0,01 €
(-1,96%)
Cap. Boursière: 20,39 M
Prix
0,51 €
Cap. Boursière
20,39 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue declined -2,96% annually over 5 years
Negative free cash flow of -27,20 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10,47%
Croissance
Revenue Growth (5Y)
-2,96%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-13,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-51,31%
Net Margin-80,29%
Op. Margin-60,50%
Sécurité
Debt / Equity
N/A
Current Ratio0,70
Interest CoverageN/A
Valorisation
PE (TTM|NTM)
-2,69 | -0,52
En dessous de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,7 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,5 |
| Net Margin % | -80,3 | -41,5 |
| Rev Growth 5Y % | -3,0 | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
3 analystes
Buy
Actuel
0,50 €
Objectif
14,00 €
5,00 €
17,00 €
20,00 €
Prévisions
P/E Prévisionnel
-0,52
BPA Prévisionnel
-0,96 €
CA Est.
16,18 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,96 €
-1,84 € – -0,24 €
|
16,18 M | 3 |
| FY2026 |
-1,15 €
-1,80 € – -0,29 €
|
8,54 M | 3 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,31 €
-0,40 € – -0,21 €
|
2,20 M | 2 |
| 2026 Q1 |
-0,29 €
-0,39 € – -0,19 €
|
1,87 M | 2 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,43 € | -0,50 € | -15,0% |
| Q32025 | -0,60 € | -0,49 € | +18,3% |
| Q22025 | -1,52 € | -0,68 € | +55,1% |
| Q12025 | -1,26 € | -1,25 € | +1,1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -13,43% | Revenue Growth (3Y) | -2,94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2,96% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9,44 M | Net Income (TTM) | -7,58 M |
| ROE | N/A | ROA | -26,66% |
| Gross Margin | N/A | Operating Margin | -60,50% |
| Net Margin | -80,29% | Free Cash Flow (TTM) | -27,20 M |
| ROIC | -51,31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,70 |
| Interest Coverage | N/A | Asset Turnover | 0,33 |
| Working Capital | -6,01 M | Tangible Book Value | -23,67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,69 | Forward P/E | -0,52 |
| P/B Ratio | N/A | P/S Ratio | 2,16 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1,26 | Fwd Earnings Yield | N/A |
| FCF Yield | -133,41% | ||
| Market Cap | 20,39 M | Enterprise Value | 11,34 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,58 | Revenue / Share | 0,24 |
| FCF / Share | -0,68 | OCF / Share | -0,68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 358,76% |
| SBC-Adj. FCF | -31,81 M | Growth Momentum | -10,47 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9,44 M | 10,91 M | 10,02 M | 10,16 M | 10,65 M |
| Net Income | -7,58 M | -43,39 M | -47,41 M | -56,67 M | -45,44 M |
| EPS (Diluted) | -0,58 | -6,88 | -8,96 | 0,61 | -0,50 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -5,71 M | -44,54 M | -48,33 M | -53,02 M | -42,07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 169 000,0 | 203 000,0 | 255 000,0 | 233 000,0 | 158 000,0 |
| Interest Expense | — | — | — | — | 0,0 |
| Income Tax | 0,0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19,97 M | 41,27 M | 77,28 M | 108,85 M | 162,30 M |
| Total Liabilities | 14,50 M | 47,26 M | 57,61 M | 62,30 M | 71,59 M |
| Shareholders' Equity | 5,46 M | -6,00 M | 19,67 M | 46,55 M | 90,71 M |
| Total Debt | — | — | — | 900 000,0 | 900 000,0 |
| Cash & Equivalents | 5,06 M | 20,00 M | 26,68 M | 19,66 M | 40,01 M |
| Current Assets | 6,92 M | 26,39 M | 60,91 M | 92,12 M | 122,38 M |
| Current Liabilities | 14,08 M | 19,03 M | 13,52 M | 10,01 M | 13,44 M |
{"event":"ticker_viewed","properties":{"ticker":"CRIS","listing_kind":"stock","pathname":"/stocks/cris","exchange":"NASDAQ","country":"US"}}